Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ (47,142) $ (19,048)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 8,538 7,971
Amortization of debt issuance costs and discount 584 448
Equity-based compensation expense 8,046 6,317
(Gain) loss on sale of joint ventures (1,303) 0
(Gain) loss on change in fair value of committed equity facility 0 179
(Gain) loss on change in fair value of warrants 8,111 2,475
Deferred provision (benefit) for income taxes (47) (1,012)
Non-cash lease expense 23 248
Non-cash interest expense 0 525
Other (74) 157
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable 14,496 2,031
(Increase) decrease in contract assets (8,754) (9,008)
(Increase) decrease in inventory (537) (221)
(Increase) decrease in prepaid insurance (208) 936
(Increase) decrease in prepaid expenses and other assets (4,039) 255
Increase (decrease) in accounts payable and accrued expenses (4,964) (2,202)
Increase (decrease) in deferred revenue (7,448) (2,734)
Increase (decrease) in operating lease liabilities (256) (241)
Increase (decrease) in other liabilities 10,551 (979)
Increase (decrease) in notes payable to sellers 11 (557)
Net cash provided by (used in) operating activities (24,412) (14,460)
Cash flows from investing activities:    
Acquisition of businesses, net of cash acquired (796) 0
Net proceeds from sale of joint ventures 4,598 0
Purchases of property, plant and equipment, net (4,064) (3,524)
Purchase of intangible assets (2,788) (1,690)
Net cash provided by (used in) investing activities (3,050) (5,214)
Cash flows from financing activities:    
Proceeds received from debt 42,971 23,696
Repayments of debt (8,183) (19,890)
Payment of debt issuance fees to third parties (780) 0
Repayment of finance leases (357) (282)
Proceeds from third-party advances 7,820 0
Proceeds from issuance of common stock 546 84
Payment of committed equity facility transaction costs 0 (571)
Payments of issuance costs related to convertible preferred stock 0 (52)
Shares repurchased for settlement of employee tax withholdings on share-based awards (1,737) (248)
Payment of contingent earnout 0 (443)
Net cash provided by (used in) financing activities 40,280 2,294
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash (2) (77)
Net increase (decrease) in cash, cash equivalents and restricted cash 12,816 (17,457)
Cash, cash equivalents and restricted cash at beginning of period 30,278 28,316
Cash, cash equivalents and restricted cash at end of period $ 43,094 $ 10,859